Literature DB >> 22542924

Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition.

A M Taylor1, A J Preston, N K Paulk, H Sutherland, C M Keenan, P J M Wilson, B Wlodarski, M Grompe, L R Ranganath, J A Gallagher, J C Jarvis.   

Abstract

OBJECTIVE: Alkaptonuria (AKU) is a rare genetic disease which results in severe early onset osteoarthropathy. It has recently been shown that the subchondral interface is of key significance in disease pathogenesis. Human surgical tissues are often beyond this initial stage and there is no published murine model of pathogenesis, to study the natural history of the disease. The murine genotype exists but it has been reported not to demonstrate ochronotic osteoarthropathy consistent with the human disease. Recent anecdotal evidence of macroscopic renal ochronosis in a mouse model of tyrosinaemia led us to perform histological analysis of tissues of these mice that are known to be affected in human AKU.
DESIGN: The homogentisate 1,2-dioxygenase Hgd(+/)(-)Fah(-)(/)(-) mouse can model either hereditary tyrosinaemia type I (HT1) or AKU depending on selection conditions. Mice having undergone Hgd reversion were sacrificed at various time points, and their tissues taken for histological analysis. Sections were stained with haematoxylin eosin (H&E) and Schmorl's reagent.
RESULTS: Early time point observations at 8 months showed no sign of macroscopic ochronosis of tissues. Macroscopic examination at 13 months revealed ochronosis of the kidneys. Microscopic analysis of the kidneys revealed large pigmented nodules displaying distinct ochre colouration. Close microscopic examination of the distal femur and proximal fibula at the subchondral junctions revealed the presence of numerous pigmented chondrocytes.
CONCLUSIONS: Here we present the first data showing ochronosis of tissues in a murine model of AKU. These preliminary histological observations provide a stimulus for further studies into the natural history of the disease to provide a greater understanding of this class of arthropathy.
Copyright © 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542924      PMCID: PMC3406176          DOI: 10.1016/j.joca.2012.04.013

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  21 in total

1.  Ascorbic acid and alkaptonuria.

Authors:  P Kamoun; M Coude; M Forest; X Montagutelli; J L Guenet
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 2.  The pathology of alkaptonuric ochronosis.

Authors:  J J Gaines
Journal:  Hum Pathol       Date:  1989-01       Impact factor: 3.466

3.  aku, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16.

Authors:  X Montagutelli; A Lalouette; M Coudé; P Kamoun; M Forest; J L Guénet
Journal:  Genomics       Date:  1994-01-01       Impact factor: 5.736

4.  The human gene for alkaptonuria (AKU) maps to chromosome 3q.

Authors:  S Janocha; W Wolz; S Srsen; K Srsnova; X Montagutelli; J L Guénet; T Grimm; W Kress; C R Müller
Journal:  Genomics       Date:  1994-01-01       Impact factor: 5.736

5.  Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

Authors:  M Grompe; S Lindstedt; M al-Dhalimy; N G Kennaway; J Papaconstantinou; C A Torres-Ramos; C N Ou; M Finegold
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

6.  Alkaptonuria in an orangutan (Pongo pygmaeus).

Authors:  M E Keeling; H M McClure; R F Kibler
Journal:  Am J Phys Anthropol       Date:  1973-03       Impact factor: 2.868

7.  Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.

Authors:  M Grompe; M al-Dhalimy; M Finegold; C N Ou; T Burlingame; N G Kennaway; P Soriano
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

8.  Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2.

Authors:  M R Pollak; Y H Chou; J J Cerda; B Steinmann; B N La Du; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

9.  Fungal metabolic model for human type I hereditary tyrosinaemia.

Authors:  J M Fernández-Cañón; M A Peñalva
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

10.  The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria.

Authors:  A M Taylor; A Boyde; P J M Wilson; J C Jarvis; J S Davidson; J A Hunt; L R Ranganath; J A Gallagher
Journal:  Arthritis Rheum       Date:  2011-12
View more
  13 in total

1.  The Distribution of Ochronosis in Osteoarthritic Articular Cartilage in a Knee.

Authors:  Vincent W Vigorita; Paul D Marino; Paul A Lucas
Journal:  HSS J       Date:  2015-10-15

2.  Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria.

Authors:  F Genovese; A S Siebuhr; K Musa; J A Gallagher; A M Milan; M A Karsdal; J Rovensky; A C Bay-Jensen; L R Ranganath
Journal:  JIMD Rep       Date:  2015-03-19

3.  Analysis of HGD Gene Mutations in Patients with Alkaptonuria from the United Kingdom: Identification of Novel Mutations.

Authors:  Jeannette L Usher; David B Ascher; Douglas E V Pires; Anna M Milan; Tom L Blundell; Lakshminarayan R Ranganath
Journal:  JIMD Rep       Date:  2015-02-15

4.  Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.

Authors:  Craig M Keenan; Andrew J Preston; Hazel Sutherland; Peter J Wilson; Eftychia E Psarelli; Trevor F Cox; Lakshminarayan R Ranganath; Jonathan C Jarvis; James A Gallagher
Journal:  JIMD Rep       Date:  2015-05-05

5.  Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing.

Authors:  Adam M Taylor; Ming-Feng Hsueh; Lakshminarayan R Ranganath; James A Gallagher; Jane P Dillon; Janet L Huebner; Jon B Catterall; Virginia B Kraus
Journal:  Rheumatology (Oxford)       Date:  2016-10-07       Impact factor: 7.580

6.  Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.

Authors:  Adam M Taylor; Koen P Vercruysse
Journal:  JIMD Rep       Date:  2016-12-10

7.  Angiogenesis in alkaptonuria.

Authors:  Lia Millucci; Giulia Bernardini; Barbara Marzocchi; Daniela Braconi; Michela Geminiani; Silvia Gambassi; Marcella Laschi; Bruno Frediani; Federico Galvagni; Maurizio Orlandini; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2016-09-26       Impact factor: 4.982

Review 8.  Alkaptonuria.

Authors:  Jemma B Mistry; Marwan Bukhari; Adam M Taylor
Journal:  Rare Dis       Date:  2013-12-18

Review 9.  Treatment of nongout joint deposition diseases: an update.

Authors:  Tristan Pascart; Pascal Richette; René-Marc Flipo
Journal:  Arthritis       Date:  2014-05-08

10.  Concentric lamellae - novel microanatomical structures in the articular calcified cartilage of mice.

Authors:  Craig M Keenan; Alison J Beckett; Hazel Sutherland; Lakshminarayan R Ranganath; Jonathan C Jarvis; Ian A Prior; James A Gallagher
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.